Re: Incidence And Risk Factors For Secondary Malignancy In Patients With Neuroblastoma After Treatment With (131)-I-Metaiodobenzylguanidine. Huibregtse K Et Al. European Journal Of Cancer 2016. 66:144-152

EUROPEAN JOURNAL OF CANCER(2017)

引用 0|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要